drug

nicotine nasal spray

Nicotine Nasal Spray
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Heinrich-Heine University, Duesseldorf
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

2
Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia
NCT01010477Phase 4Completed
Social Cognition,Attentional Network and Nicotine Drug Dependency - A Pharmacological Clinical Trail
NCT00618280Phase 1, Phase 2Completed

KOLs & investigators

2
G. Winterer, Prof. Dr.
Jill M. Williams, MD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Heinrich-Heine University, Duesseldorf
company
trial
Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia
PHASE4
trial
Social Cognition,Attentional Network and Nicotine Drug Dependency - A Pharmacological Clinical Trail
PHASE1, PHASE2
trial
indication
Schizophrenia
indication
Smoking Cessation
indication
Tobacco Use Disorder
indication
Smoking Cessation
indication
KOL
G. Winterer, Prof. Dr.
KOL score —
person
Jill M. Williams, MD
KOL score —
person